How has Tectonic Therapeutics's other commercial liabilities changed year-over-year?

Tectonic Therapeutics's other commercial liabilities increased by 82.9% year-over-year, from $4.91M to $8.97M.

What is the long-term trend for Tectonic Therapeutics's other commercial liabilities?

Over 5 years (2020 to 2025), Tectonic Therapeutics's other commercial liabilities has grown at a -11.7% compound annual growth rate (CAGR), from $13.69M to $7.34M.

Tectonic Therapeutics TECX Other Commercial Liabilities

Other Commercial Liabilities at other companies

ALN

Alnylam PharmaceuticalsALNY

——

Septerna, Inc.SEPN

——

Opko HealthOPK

——

Ethos Technologies, Inc. LIFE

——

CRISPR TherapeuticsCRSP

——

Arrowhead ResearchARWR

——

Other financials

Income statement

See full

Operating income-$27.3M-49.2%

Net income-$25.2M-58.7%

EPS (diluted)-$1.34-44.1%

Balance sheet

See full

Cash & equivalents$236.9M-22.8%

Total debt$4.9M+86.1%

Total equity$230.4M-23.5%

Total assets$246.6M-21.7%

Cash flow

See full

Operating cash flow-$18.4M-40.7%

CapEx$19.0K-29.6%

Free cash flow-$18.4M-40.6%

Valuation

See full

Market cap$585.51M+58.3%

Enterprise value$353.51M+438%

Returns & leverage

See full

Return on equity-31.4%—

Debt / equity0×0.0×

Current ratio18.5×-4.4×

Where this comes from

Reported directly by Tectonic Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: Tectonic Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tectonic Therapeutics's other commercial liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Tectonic Therapeutics's other commercial liabilities?: Tectonic Therapeutics (TECX) reported other commercial liabilities of $8.97M in Q1 2026.
How has Tectonic Therapeutics's other commercial liabilities changed year-over-year?: Tectonic Therapeutics's other commercial liabilities increased by 82.9% year-over-year, from $4.91M to $8.97M.
What is the long-term trend for Tectonic Therapeutics's other commercial liabilities?: Over 5 years (2020 to 2025), Tectonic Therapeutics's other commercial liabilities has grown at a -11.7% compound annual growth rate (CAGR), from $13.69M to $7.34M.